NIH Is `Century's Finest Social Invention'

Editor's Note: In his latest book, The Fragile Species (New York, Charles Scribner's Sons, 1992), scientist-author Lewis Thomas offers a collection of 14 essays, covering a wide range of personal, social, and scientific issues. Prominent among these is the relationship of basic scientific research, the achievements of modern medicine, and the future promise of an ever-healthier population. However, Thomas--who is president, emeritus, of the Memorial Sloan-Kettering Cancer Center in New York and

| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

My contention is that we do indeed have some science in the practice of medicine, but not anything like enough, and we have a great distance to go. Indeed, most of what is regarded as high science in medicine is actually a set of technologies for diagnostic precision--the CAT scan, NMR, and many exquisite refinements of our methods for detecting biochemical abnormalities of one sort or another. But these have not yet been matched by any comparable transformations in therapy. We are still confronted by the chronic disablements of an aging population, lacking any clear understanding of the mechanisms of these diseases--dementia, for instance, or diabetes or cirrhosis or arthritis or stroke and all the rest on a long list--and without knowing the underlying mechanisms we lack new therapeutic approaches.

To be sure, we do have some spectacular surgical achievements in the headlines--the transplantation of hearts, kidneys, livers, and the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Lewis Thomas

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo